Association of high sensitive C-reactive protein and lipid markers in predicting atherosclerotic cardiovascular risk in dyslipidemic women
DOI:
https://doi.org/10.12923/cipms-2026-0003Abstrakt
This study found a strong association between elevated levels of highly sensitive C-reactive protein (hs-CRP) and vital lipid markers in dyslipidemic pre-, peri-,and postmenopausal women, indicating the need to screen them early for atherosclerotic cardiovascular risk. These subjects were advised to make dietary and lifestyle changes to overcome dyslipidemia and prevent the development and progression of atherosclerotic cardiovascular disease (ASCVD) during menopause. No such studies have examined the relationship between hs-CRP and lipid markers, especially in dyslipidemic women. Surprisingly, significant associations were also observed between hs-CRP and triglycerides (TG), as well as between hs-CRP and LDL-cholesterol (LDL-C) in premenopausal women with dyslipidemia. These correlations suggest that hs-CRP and the studied lipid markers are better indicators of the possible onset of ASCVD in women at later ages.
Bibliografia
1. Chandrakala, Venkatesh Desai. Study of Acute Myocardial Infarction in Post Menopausal Women with Special Reference to Dyslipidemia. Indian J Emerg Med. 2017;3(1).
2. Ko SH, Kim HS. Menopause-Associated Lipid Metabolic Disorders and Foods Beneficial for Postmenopausal Women. Nutrients. 2020; 12(1):202. https://doi.org/10.3390/nu12010202.
3. William B, Riaz I, Mubashir S, Aslam K, Aysha S, Anjum I. Dyslipidemia as a risk factor for developing hypertension and cardiovascular disease in females of reproductive age. J Nat Appl Sci Pak. 2019;1(2):139-47.
4. Parinita K. Study of serum lipid profile in individuals residing in and around Nalgonda. Int J Pharm Biol Sci. 2012;2(1):110-16.
5. Kanthe PS, Patil BS, Bagali S, Deshpande A, Shaikh G, Aithala M. Atherogenic Index as a Predictor of Cardiovascular Risk among Women with Different Grades of Obesity. Int J Collab Res Intern Med Public Health. 2012;4(10):1767-74.
6. Stevens W, Peneva D, Li JZ, Liu LZ, Liu G, Gao R, et al. Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China. BMC Health Serv Res. 2016;16(1):75. https://doi.org/10.1186/s12913-016-1318-5.
7. Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;5(4):1218-40. https://doi.org/10.3390/nu5041218.
8. Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, Abrishami M, Juya M, Khodaee G, et al. Atherogenic index of plasma (AIP): a marker of cardiovascular disease. Med J Islam Repub Iran. 2015;29: 240. PMID: 26793631.
9. World Health Organization. Global status report on non-communicable diseases 2014. Geneva: World Health Organization; 2014.
10. Gupta R, Guptha S, Agrawal A, Kaul V, Gaur K, Gupta VP. Secular trends in cholesterol lipoproteins and triglycerides and prevalence of dyslipidemias in an urban Indian population. Lipids Health Dis. 2008;7:40. https://doi.org/10.1186/1476-511X-7-40
11. Enas EA, Dharmarajan TS, Varkey B. Consensus statement on the management of dyslipidemia in Indian subjects: A different perspective. Indian Heart J. 2015;67(2):95-102. https://doi.org/10.1016/j.ihj.2015.03.020
12. Ridker PM. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation. 2003;108(12):e81-5. https://doi.org/10.1161/01.CIR.0000093381.57779.67.
13. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19(4):387-95. https://doi.org/10.1097/gme.0b013e31824d8f40
14. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20(4):470-5. PMID: 4818200
15. Spayd RW, Bruschi B, Burdick BA, Dappen GM, Eikenberry JN, Esders TW, et al. Multilayer film elements for clinical analysis: applications to representative chemical determinations. Clin Chem. 1978;24(8):1343-50. PMID: 668120
16. Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 1970;11(6):583-95. PMID: 4098499
17. Han X, Fox DS, Chu M, Dougherty JS, McCombs J. Primary Prevention Using Cholesterol-Lowering Medications in Patients Meeting New Treatment Guidelines: A Retrospective Cohort Analysis. J Manag Care Spec Pharm. 2018;24(11):1078-85. https://doi.org/10.18553/jmcp.2018.24.11.1078
18. Cifkova R, Lovic AK. Dyslipidemia and Cardiovascular Disease in Women. Curr Cardiol Rep. 2015;17(7):609. https://doi.org/10.1007/s11886-015-0609-5
19. Baranwal JK, Maskey R, Majhi S, Lamsal M, Baral N. Utility of hsCRP as an add on to Lipid Profile for Cardiovascular risk stratification in adults with Type 2 Diabetes mellitus. J Diab Endo Assoc Nepal. 2021;5(1):19-24. https://doi.org/10.3126/jdean.v5i1.37324
20. Koley S, Arindam S. Association of Lipid Profile Parameters with High-Sensitive C-reactive Protein (hsCRP) in Patients with Dyslipidemia. Ann Med Health Sci Res. 2018;8:105-7
21. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med. 2004;351(25):2599-610. https://doi.org/10.1056/NEJMoa040967
22. Randolph JF Jr, Zheng H, Sowers MR, Crandall C, Crawford S, Gold EB, et al. Change in follicle stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab. 2011;96(3):746-54. https://doi.org/10.1210/jc.2010-1746
23. Lamarche B, Lemieux I, Després JP. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, pathophysiology and therapeutic aspects. Diabetes Metab. 1999; 25(3):199-211. PMID: 10499189
24. Wilkinson IB, Cockcroft JR. Cholesterol, lipids and arterial stiffness. Adv Cardiol. 2007;44:261-77. https://doi.org/10.1159/000096747
25. Klisic AN, Vasiljevic ND, Simic TP, Djukic TI, Maksimovic MZ, Matic MG. Association between C-reactive protein, anthropometric and lipid parameters among healthy normal weight and overweight postmenopausal women in Montenegro. Lab Med. 2014;45(1):12-6. https://doi.org/10.1309/LMMI5A9T9TFFOQBI
Pobrania
Opublikowane
Numer
Dział
Licencja
Prawa autorskie (c) 2026 Samatha Pavuluri, Siva Prabodh Vuddandi, Xavier Santhiyaju, Ethirajan Sukumar (Autor)
Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa – Użycie niekomercyjne – Bez utworów zależnych 4.0 Międzynarodowe.
